2-CYANO-4-FLUOROPYRROLIDINE DERIVATIVE OR ITS SALT

Details for Australian Patent Application No. 2003281625 (hide)

Owner YAMANOUCHI PHARMACEUTICAL CO., LTD.

Inventors Negoro, Kenji; Hayakawa, Masahiko; Maruyama, Tatsuya; Miyamoto, Satoshi; Suzuki, Takayuki; Nakano, Ryosuke

Agent Davies Collison Cave

Pub. Number AU-A-2003281625

PCT Number PCT/JP2003/0091

PCT Pub. Number WO2004/009544

Priority 2002-213654 23.07.02 JP; 2002-264450 10.09.02 JP

Filing date 18 July 2003

Wipo publication date 9 February 2004

International Classifications

C07D 207/16 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 031/4025 - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 031/4155 - not condensed and containing further heterocyclic rings

A61K 031/439 - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 031/454

A61K 031/4545

A61K 031/5377

A61K 031/541 - Non-condensed thiazines containing further heterocyclic rings

A61P 003/10 Drugs for disorders of the metabolism

A61P 043/00 Drugs for specific purposes, not provided for in groups

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 451/04 Heterocyclic compounds containing condensed hetero ring systems

Event Publications

4 March 2004 Complete Application Filed

  Priority application(s): 2002-213654 23.07.02 JP; 2002-264450 10.09.02 JP

18 March 2004 Application Open to Public Inspection

  Published as AU-A-2003281625

22 December 2005 Assignment before Grant

  Yamanouchi Pharmaceuticals Co., Ltd. The application has been assigned to Astellas Pharma Inc. Assignments before Grant, Section 113

12 February 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003281626-NOVEL GENE ASSOCIATED WITH RHEUMATOID ARTHRITIS

2003281624-SEWAGE TREATMENT PROCESS BY ACTIVATED-SLUDGE METHOD COMPRISING LINE ATOMIZING TREATMENT